title: Inhibition of hepatic and cutaneous biotransformation of resorufin ethers following intraperitoneal administration of 1-aminobenzotriazole.
authors.affiliation: Department of Drug Metabolism, Hoffmann-La Roche, Nutley, New Jersey 07110.
authors.forename: N F
authors.initials: NF
authors.lastname: Oldfield
authors.forename: M
authors.initials: M
authors.lastname: Mortillo
authors.forename: W A
authors.initials: WA
authors.lastname: Garland
authors.forename: B A
authors.initials: BA
authors.lastname: Mico
mesh_terms: D000818:Animals; D001711:Biotransformation / Q000187:drug effects; D003577:Cytochrome P-450 Enzyme System / Q000378:metabolism; D003640:Dealkylation; D004987:Ethers / Q000493:pharmacokinetics; D007274:Injections, Intraperitoneal; D008297:Male; D051379:Mice; D008862:Microsomes, Liver / Q000187:drug effects / Q000378:metabolism*; D010078:Oxazines / Q000378:metabolism / Q000493:pharmacokinetics*; D012867:Skin / Q000187:drug effects / Q000378:metabolism*; D014230:Triazoles / Q000008:administration & dosage / Q000494:pharmacology*
chemical_list: D004987:Ethers; D010078:Oxazines; D014230:Triazoles; C033020:1-aminobenzotriazole; C014180:resorufin; D003577:Cytochrome P-450 Enzyme System